Research Article

The Influence of Menopause and Inflammation on Redox Status and Bone Mineral Density in Patients with Rheumatoid Arthritis

Table 2

Comorbidities in the study population.

ComorbiditiesHealthy controlsRheumatoid patients
Premenopausal control ()Postmenopausal control ()Premenopausal patient ()Postmenopausal patient ()

Hypertension2 (14.9)16 (47.1)1 (9.1)17 (54.8)
Arrhythmia2 (14.9)2 (5.9)2 (18.2)3 (9.7)
Hyperthyroidism1 (2.8)1 (2.9)1 (9.1)/
Hashimoto thyroiditis1 (2.8)1 (2.9)1 (9.1)2 (6.5)
Hypercholesterolemia/2 (5.9)1 (9.1)1 (3.2)
Gallbladder calculosis///2 (6.5)
Bronchial asthma///2 (6.5)
Peptic ulcer1 (2.8)2 (5.9)/3 (9.7)
Gout/1 (2.9)//
Glaucoma1 (2.8)///
Migraine/1 (2.9)//

Data are presented as a number of participants (%).